Context Therapeutics Inc. - Common Stock, par value $0.001 per share (CNTX)

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 92,935,152
Number of holders: 16
Total 13F shares, excl. options: 3,549,370
Shares change: +3,190,153
Total reported value, excl. options: $9,441,000
Value change: +$8,486,000
Number of buys: 14
Price: $2.66

Significant Holders of Context Therapeutics Inc. - Common Stock, par value $0.001 per share (CNTX) as of Q4 2021

16 filings reported holding CNTX - Context Therapeutics Inc. - Common Stock, par value $0.001 per share as of Q4 2021.
Context Therapeutics Inc. - Common Stock, par value $0.001 per share (CNTX) has 16 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 3,549,370 shares of 92,935,152 outstanding shares and own 3.82% of the company stock.
Largest 10 shareholders include SABBY MANAGEMENT, LLC (1,230,830 shares), AIGH Capital Management LLC (762,721 shares), Altium Capital Management LP (493,531 shares), Empery Asset Management, LP (358,617 shares), VANGUARD GROUP INC (214,679 shares), Worth Venture Partners, LLC (174,967 shares), Veritable, L.P. (110,249 shares), RENAISSANCE TECHNOLOGIES LLC (64,618 shares), Virtu Financial LLC (53,521 shares), and swisspartners Ltd. (42,235 shares).
This table shows the top 16 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

Investor	Option	Weight %	Change %	Value $	* Price $	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.